All Type of News
The hypervalent orphan drug, ‘Soliris’, has been a target for a clinical trial to improve indication in Korea
A clinical trial will be conducted to improve indication for the paroxysmal nocturnal hemoglobinuria (PHN) treatment ‘Soliris (generic name: eculizumab)’ reaching KRW 400 million administration expenses every year.
T...
Most professional managers expiring terms of services in pharmaceutical companies will be reappointed
Shareholders’ general meetings of listed pharmaceutical companies will be held either on 20 and 27 March.
Through recent public announcements, listed pharmaceutical companies spoke that many of them will hold shareho...
The plant and pharmaceutical export contract between Korea and Saudi Arabia on a scale worth of KRW 200 billion
Plants worth of KRW 200 billion and pharmaceutical export contracts between Korea and Saudi Arabia has been made, and Korean medical institutions will first be established in Saudi Arabia.
Taking the President Geun-h...
Generics of Baraclude and Amosartan meet requirements for the Exclusive Sale Rights
As the Patent Linkage System passed the National Assembly, it is expected that some generics will acquire the Prioritized Sale Item Approval (Exclusive Sale Right) this year.
If the system will get enforced on the co...
Which one will be the top pharmaceutical export country between China and Japan?
A voice has been raised that exports of cosmetics has to be separately recorded when the domestic pharmaceutical export statistics are unveiled.
According to the 2014 pharmaceutical export countries disclosed by the ...
The NHIS has raised the damage to KRW 1.2 billion for the GSK and Dong-A ST’s price fixing
The National Health Insurance Service (NHIS) recomputed damages at KRW 1.2 billion for the lawsuit against GlaxoSmithKline and Dong-A ST that has fixed the price of the antiemetic treatment ‘Ondaron’.
“GSK and Dong-A...
How is the pharmaceutical industry getting ready for the enforcement of the Patent Linkage System?
Facing the enforcement of the ‘Patent Linkage System’ on the coming 15 March, the National Assembly plenary session has passed the Pharmaceutical Law Amendment including the ‘Priority Sale Item Approval System’ and th...
Pharmaceutical sales on January were KRW 1.475 trillion, growing 4.8% up compared to the last year
It is known that sales of pharmaceutical products on the last January increased 4.8% up with KRW 1.475 trillion compared to the last year.
Shinhan Investment Corp. unveiled through its analysis report on the 3rd that...
President Park stated “Followed by the Middle East, the next new market is Latin America for the pharmaceutical industry”
While touring the Middle East, President Guen-hye Park is scheduled to visit Latin America next month; thus, it is noticed whether the healthcare industry will earn a beneficial result from the president.
According t...
‘The pharmaceutical industry is looking to occupy the KRW 15 billion neutropenia treatment market’
The neutropenia treatment market, expected to form a KRW 15 billion market for the first time and grow significantly every year, will get into a competing structure.
It is known that the top pharmaceutical companies ...
